Valproic Acid and Bevacizumab in Patients With Advanced Cancer
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of bevacizumab
in combination with valproic acid that can be given to patients with advanced cancer that has
not responded to standard treatment or where there is no standard treatment for the disease.
The safety of this drug combination will also be studied.